Dr Jackie Fairley has more than 30 years of experience in the pharmaceutical and biotechnology industries working in senior management roles with companies including CSL and Faulding (now Pfizer)
She recently stepped down as Chief Executive Officer and Managing Director of ASX-listed Starpharma Holdings, a role she had held since 2006. As CEO of Starpharma Jackie led the development and commercialization of multiple pharmaceutical products including three clinical-stage oncology therapeutics and a number of anti-infectives. Her industry experience spans all facets pharmaceutical product development, international registration, licensing, financing and commercialisation.
Dr Fairley is also a Director of ASX-listed Mirrabooka Investments and past Director of the Melbourne Business School. She is a member of the Victorian Trade and Investment Advisory Board and was an advisor to the Carnegie Innovation Fund for more than 10 years. She is a past member of the Federal Government’s Commonwealth Science Council, Pharmaceutical Industry Working Group and several other Ministerial advisory groups spanning pharmaceuticals, economic development and innovation.
Jackie holds 1st class honours degrees from the University of Melbourne in Science (Pharmacology/Pathology) and Veterinary Science. She also holds an MBA from the Melbourne Business School for which she was awarded the prestigious Clemenger Medal, is Graduate of the AICD and a Fellow of the Academy of Technological Sciences and Engineering (FTSE).